FDA Label for Pnv Prenatal Plus Multivitamin
View Indications, Usage & Precautions
Pnv Prenatal Plus Multivitamin Product Label
The following document was submitted to the FDA by the labeler of this product A-s Medication Solutions. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Description
Each PNV Tablet Contains: | Amount Per Serving |
---|---|
Vitamin A (from Acetate and Beta Carotene) | 4000 I.U. |
Vitamin C (Ascorbic Acid) | 120 mg |
Vitamin D-3 (Cholecalciferol) | 400 I.U. |
Vitamin E (dl-Alpha Tocopheryl Acetate) | 22 mg |
Vitamin B-1 (from Thiamine Mononitrate) | 1.84 mg |
Vitamin B-2 (Riboflavin) | 3 mg |
Niacin (as Niacinamide) | 20 mg |
Vitamin B-6 (from Pyridoxine HCl) | 10 mg |
Folic Acid | 1 mg |
Vitamin B-12 (Cyanocobalamin) | 12 mcg |
MINERALS: | |
Calcium (as Calcium Carbonate) | 200 mg |
Iron (from Ferrous Fumarate) | 27 mg |
Zinc (from Zinc Oxide) | 25 mg |
Copper (from Cupric Oxide) | 2 mg |
Other Ingredients: Croscarmellose Sodium, Microcrystalline Cellulose, Talc, Magnesium Stearate.
Indications
To provide Vitamin and Mineral supplementation throughout pregnancy and during the postnatal period for both the lactating and non-lactating mother. It is also useful for improving nutritional status prior to conception.
Dosage
As a dietary adjunct before, during and after pregnancy, take one tablet daily with a meal, or as directed by a physician.
Warning
Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of the reach of children. In case of accidental overdose, call a doctor or poison control center immediately.
Precautions
Folic Acid may mask the symptoms of hematological damage due to Vitamin B12 deficiency of pernicious anemia while the associated neurological damage progresses.
Storage And Handling
STORE AT CONTROLLED ROOM TEMPERATURE 15°-30°C (59°-86°F). AVOID EXCESS HEAT. Dispense in a well closed light-resistant container, with a child resistant cap.
This medical food product is formulated to be administered orally, under the supervision of a physician.
KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.
Other
Manufactured by:
Sancilio & Company, Inc.
3874 Fiscal Court
Riviera Beach, FL 33404
(800)SCI-8711
REV: 04/11/13
How Supplied
Product: 50090-0617
NDC: 50090-0617-0 100 TABLET in a BOTTLE, PLASTIC
NDC: 50090-0617-1 30 TABLET in a BOTTLE
* Please review the disclaimer below.